Integrated Learning Support System Based on Immersive Simulated Training for Nursing Students
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Brasilia
About this trial
This study aims to evaluate the effectiveness of an Integrated Learning Support System (ILSS) in preparing undergraduate nursing students for immersive simulated training in managing drug-induced nephrotoxicity. The study hypothesizes that the ILSS, which accommodates different learning styles, will be more effective in reducing stress and anxiety compared to the standard learning model (SLM). The research will involve a parallel randomized controlled trial with 96 students from two Brazilian institutions. The students will be divided into control and experimental groups, with the latter using the ILSS in addition to SLM during preparation. The study will assess outcomes such as knowledge acquisition, skill development, and stress reduction using various instruments, including the Lasater Clinical Judgment Rubric and DASS-21. The study's findings aim to validate the ILSS as a tool to enhance learning outcomes and reduce stress and anxiety, thereby promoting better professional development and patient safety in nursing practice.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Be aged ≥ 18 years old;
Students enrolled in the last two years of the undergraduate nursing course;
Students who have self-declared internet access in their homes to complete the course's online modules.
Disqualifiers
Students who have previous training and/or professional experience in the health area;
Students who do not complete at least 75% of the workload of the proposed course.
Trial design
Design model
Parallel
Treatments tested in this trial
Integrated Learning Support System
Other interventionStudents will receive simulation preparation with an Integrated Learning Support System consisting of: * Educational technology in comic book format * Virtual monitoring system with tutors * Psychological follow-up * Music listening and relaxation session
Standard Learning Model
Other interventionStudents will receive standard simulation preparation consisting of: \- Expository and dialogued theoretical class.
Treatment groups
95 Participants
are divided into 2 treatment groupsGroup A: Integrated Learning Support System (ILSS)Experimental treatment 1 intervention
Group B: Standard Learning Model (SLM)Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
Knowledge about Prevention of Contrast-Induced Nephrotoxicity (baseline)
Assessment of knowledge about prevention of contrast-induced nephrotoxicity using a standardized questionnaire. Unit of Measure: Percentage of correct responses
Time frame
Evaluated one week before participation in the simulation scenario.2
Knowledge about Prevention of Contrast-Induced Nephrotoxicity (one week before simulation)
Assessment of knowledge about prevention of contrast-induced nephrotoxicity using a standardized questionnaire. Unit of Measure: Percentage of correct responses
Time frame
Evaluated Immediately after participation in the simulation scenario3
Knowledge about Prevention of Contrast-Induced Nephrotoxicity (thirty days after simulation)
Assessment of knowledge about prevention of contrast-induced nephrotoxicity using a standardized questionnaire. Unit of Measure: Percentage of correct responses
Time frame
Evaluated Thirty days after participation in the simulation scenarioSecondary outcomes
1
Practical Performance in Realistic Simulation
This measure evaluates the student's ability to perform specific tasks and procedures accurately and efficiently in a simulated clinical environment. Assessment of student's practical performance during the realistic simulation scenario using a standardized performance checklist. Unit of Measure: Percentage of completed tasks according to the performance checklist. Measurement Tool: Standardized performance checklist
Time frame
During the simulated scenario.2
Clinical Judgment on Prevention of Contrast-Induced Nephrotoxicity (baseline)
Assessment of clinical judgment regarding the prevention of contrast-induced nephrotoxicity using the Lasater Clinical Judgment Rubric - Brazilian Version (LCJR-BV). Unit of Measure: Scores on the LCJR-BV, which range from 11 to 44 points. The scoring system is designed to identify the level of clinical performance presented by an individual and includes four levels for each of the 11 dimensions: One point for each behavior considered "Novice" Two points for behavior considered "Developing" Three points for behavior considered "Proficient" Four points for behavior considered "Exemplary" Scores between 11 and 19 points are considered "Novice"; scores between 20 and 28 points are considered "Developing"; scores between 29 and 37 points are considered "Proficient"; and scores between 38 and 44 points are considered "Exemplary".
Time frame
Evaluated one week before participation in the simulation scenario3
Clinical Judgment on Prevention of Contrast-Induced Nephrotoxicity (immediately after simulation)
Assessment of clinical judgment regarding the prevention of contrast-induced nephrotoxicity using the Lasater Clinical Judgment Rubric - Brazilian Version (LCJR-BV). Unit of Measure: Scores on the LCJR-BV, which range from 11 to 44 points. The scoring system is designed to identify the level of clinical performance presented by an individual and includes four levels for each of the 11 dimensions: One point for each behavior considered "Novice" Two points for behavior considered "Developing" Three points for behavior considered "Proficient" Four points for behavior considered "Exemplary" Scores between 11 and 19 points are considered "Novice"; scores between 20 and 28 points are considered "Developing"; scores between 29 and 37 points are considered "Proficient"; and scores between 38 and 44 points are considered "Exemplary".
Time frame
Evaluated immediately after participation in the simulation scenario4
Clinical Judgment on Prevention of Contrast-Induced Nephrotoxicity (thirty days after simulation)
Assessment of clinical judgment regarding the prevention of contrast-induced nephrotoxicity using the Lasater Clinical Judgment Rubric - Brazilian Version (LCJR-BV). Unit of Measure: Scores on the LCJR-BV, which range from 11 to 44 points. The scoring system is designed to identify the level of clinical performance presented by an individual and includes four levels for each of the 11 dimensions: One point for each behavior considered "Novice" Two points for behavior considered "Developing" Three points for behavior considered "Proficient" Four points for behavior considered "Exemplary" Scores between 11 and 19 points are considered "Novice"; scores between 20 and 28 points are considered "Developing"; scores between 29 and 37 points are considered "Proficient"; and scores between 38 and 44 points are considered "Exemplary".
Time frame
Evaluated thirty days after participation in the simulation scenarioSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: